COVID-19 drug prospects boosted by discovery of short form of coronavirus’s ‘entry point’
Making sense of the lagging U.S. COVID-19 vaccination effort
11 January 2021Delaying second COVID-19 vaccine doses will make supplies last longer but comes with risks
11 January 2021COVID-19 drug prospects boosted by discovery of short form of coronavirus’s ‘entry point’
A shadow over the promising inhaled interferon beta COVID-19 therapy has been cleared with the discovery that although it appears to increase levels of ACE2 protein—coronavirus’ key entry point into nose and lung cells—it predominantly increases levels of a short version of that protein, which the virus cannot bind to.
